Education
About Us
Working with TipRanks
Follow Us
Eton Pharmaceuticals Inc (ETON)
NASDAQ:ETON
ETON Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.03 - $18.41
Previous CloseN/A
Volume127.06K
Average Volume (3M)287.75K
Market Cap
$364.63M
Enterprise Value$143.37M
Total Cash (Recent Filing)$14.71M
Total Debt (Recent Filing)$6.53M
Price to Earnings (P/E)―
Beta0.81
Next Earnings
Mar 18, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding26,634,796
10 Day Avg. Volume232,794
30 Day Avg. Volume287,751
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)10.87
Price to Cash Flow (P/CF)31.90
P/FCF Ratio29.80
Enterprise Value/Market Cap0.39
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit6.81
Enterprise Value/Ebitda-32.49
Forecast
1Y Price Target
$27.00Price Target Upside97.22% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
Bulls Say, Bears Say
Bulls Say
Product LaunchThe re-launch of newly acquired Increlex and Galzin products is expected to drive commercial excellence and accelerate growth.
Revenue GrowthEton Pharmaceuticals is getting closer to its target $100M+ annual revenue run-rate, indicating sustainable profitability in the near term.
Bears Say
Regulatory DelaysThe 3-month PDUFA delay is unrelated to clinical or manufacturing issues, which suggests no significant setbacks for Eton Pharmaceuticals.
---
Ownership Overview
15.28% Insiders
7.33% Mutual Funds
35.95% Other Institutional Investors
37.43% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ETON FAQ
What was Eton Pharmaceuticals Inc’s price range in the past 12 months?
Eton Pharmaceuticals Inc lowest stock price was $3.03 and its highest was $18.41 in the past 12 months.
What is Eton Pharmaceuticals Inc’s market cap?
Eton Pharmaceuticals Inc’s market cap is $364.63M.
When is Eton Pharmaceuticals Inc’s upcoming earnings report date?
Eton Pharmaceuticals Inc’s upcoming earnings report date is Mar 18, 2025 which is in 6 days.
How were Eton Pharmaceuticals Inc’s earnings last quarter?
Eton Pharmaceuticals Inc released its earnings results on Nov 12, 2024. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of -$0.01 by $0.03.
Is Eton Pharmaceuticals Inc overvalued?
According to Wall Street analysts Eton Pharmaceuticals Inc’s price is currently Undervalued.
Does Eton Pharmaceuticals Inc pay dividends?
Eton Pharmaceuticals Inc does not currently pay dividends.
What is Eton Pharmaceuticals Inc’s EPS estimate?
Eton Pharmaceuticals Inc’s EPS estimate is >-0.01.
How many shares outstanding does Eton Pharmaceuticals Inc have?
Eton Pharmaceuticals Inc has 26,634,796 shares outstanding.
What happened to Eton Pharmaceuticals Inc’s price movement after its last earnings report?
Eton Pharmaceuticals Inc reported an EPS of $0.02 in its last earnings report, beating expectations of -$0.01. Following the earnings report the stock price went up 15.594%.
Which hedge fund is a major shareholder of Eton Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in ETON
---
Eton Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$27.00 (97.22% Upside)
$27.00 (97.22% Upside)
Blogger Sentiment
Bullish
ETON Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $79.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.3%
Last 30 Days ▼ 17.0%
Last 30 Days ▼ 17.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
204.22%
12-Months-Change
Fundamentals
Return on Equity
-33.35%
Trailing 12-Months
Asset Growth
13.69%
Trailing 12-Months
Company Description
Eton Pharmaceuticals Inc
Eton Pharmaceuticals, Inc. engages in the development and commercialization of prescription drug products. Its portfolio consists of injectable, oral liquid, ophthalmic products pipelines. The company was founded in April 2017 and is headquartered in Deer Park, IL.
---
ETON Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call was predominantly positive, highlighting significant revenue growth, a strategic acquisition, and achieving profitability ahead of schedule. While there were challenges such as increased administrative expenses and higher discontinuation rates for a specific product, they were outweighed by the company's overall achievements and strategic advancements.Read More>---
ETON Stock 12 Month Forecast
Average Price Target
$27.00
▲(97.22% Upside)
Technical Analysis
Best Analysts Covering ETON
1 Year
1 Year Success Rate
7/9 ratings generated profit
1 Year Average Return
+108.29%
reiterated a buy rating 9 days ago
Copying Chase Knickerbocker's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +108.29% per trade.
---